Orgenesis Inc ORGS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
0.5129quote price arrow up+0.0109 (+2.1713%)
Volume
11,364
52 week range
0.25 - 1.50
Loading...
  • Open0.51
  • Day High0.5209
  • Day Low0.50
  • Prev Close0.502
  • 52 Week High1.50
  • 52 Week High Date06/30/23
  • 52 Week Low0.25
  • 52 Week Low Date02/09/24

Key Stats

  • Market Cap17.612M
  • Shares Out34.34M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change0.66

KEY STATS

  • Open0.51
  • Day High0.5209
  • Day Low0.50
  • Prev Close0.502
  • 52 Week High1.50
  • 52 Week High Date06/30/23
  • 52 Week Low0.25
  • 52 Week Low Date02/09/24
  • Market Cap17.612M
  • Shares Out34.34M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change0.66

RATIOS/PROFITABILITY

  • EPS (TTM)-1.97
  • P/E (TTM)-0.26
  • Fwd P/E (NTM)1.12
  • EBITDA (TTM)-50.643M
  • ROE (TTM)-1,683.22%
  • Revenue (TTM)529,999.971
  • Gross Margin (TTM)-1,080.19%
  • Net Margin (TTM)-12,248.68%
  • Debt To Equity (MRQ)-106.32%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Orgenesis Inc

 

Profile

MORE
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities...
Vered Caplan
Chairperson of the Board of Directors, Chief Executive Officer
Victor Miller
Chief Financial Officer
Address
20271 Goldenrod Lane
Germantown, MD
20876
United States

Top Peers

SYMBOLLASTCHG%CHG
EIGRQ
Eiger BioPharmaceuticals Inc
3.04-0.76-19.95%
NTII
Neurobiological Technologies Inc
0.00UNCHUNCH
EIGRQ
Eiger BioPharmaceuticals Inc
3.04-0.76-19.95%
SQZB
SQZ Biotechnologies Co
0.0465UNCHUNCH
AFFY
Affymax Inc
0.0007UNCHUNCH